Unknown

Dataset Information

Short- and medium-term outcomes after transcatheter pulmonary valve placement in the expanded multicenter US melody valve trial.


ABSTRACT:

Background

Transcatheter pulmonary valve placement is an emerging therapy for pulmonary regurgitation and right ventricular outflow tract obstruction in selected patients. The Melody valve was recently approved in the United States for placement in dysfunctional right ventricular outflow tract conduits.

Methods and results

From January 2007 to August 2009, 136 patients (median age, 19 years) underwent catheterization for intended Melody valve implantation at 5 centers. Implantation was attempted in 124 patients; in the other 12, transcatheter pulmonary valve placement was not attempted because of the risk of coronary artery compression (n=6) or other clinical or protocol contraindications. There was 1 death from intracranial hemorrhage after coronary artery dissection, and 1

SUBMITTER: McElhinney DB 

PROVIDER: S-EPMC4240270 | biostudies-literature | 2010 Aug

REPOSITORIES: biostudies-literature